A new paper explores the topic of proprietary blends in dietary supplements, with one of the authors noting that industry needs to take a position on an issue that pits transparency on one side against intellectual property protection on the other.
The animal supplement market has come a long way, says Bill Bookout, president and cofounder of the National Animal Supplement Council (NASC), which has made it its mission to ensure the survival and quality of animal supplements on the market.
Over the course of the next year, lawmakers on the US House and Senate agriculture committees will draft a new federal Farm Bill that will shape a number of programs for the next five years. What does that mean for the hemp industry?
Hofseth BioCare (HBC) has successfully achieved New Dietary Ingredient (NDI) status from the US Food and Drug Administration for its ProGo bioactive peptides, having already achieved this for its CalGo and OmeGo ingredients.
The FDA appears to be moving ahead with a proposed rule to allow NAC (N-acetyl cysteine) as a dietary ingredient for use in supplements, according to a newly published guidance.
A new study from a team headed by prominent industry critic Dr Pieter Cohen, MD, found that FDA warning letters did not prevent the subsequent sale of supplements with dodgy ingredients.
The American Herbal Products Association is urging members and stakeholders to contact lawmakers to oppose the mandatory product listing language that has been attached to a ‘must pass’ fee reauthorization bill.
A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.
Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.
Mandatory Product Listing can still be a good idea for industry, proponents maintain, even if the latest legislative iteration has failed to garner support from stakeholders.
Three trade organizations joined forces in opposing the FDA Safety and Landmark Advancement Act of 2022 (FDASLA), a fee authorization bill that includes provisions aimed at tightening dietary supplement regulations.
FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.
The IPA World Congress + Probiota Americas 2022 is just over a month away! The leading event for the probiotics, prebiotics, and microbiome community is a must-attend event, and let us tell you why…
According to the 2021 CRN Consumer Survey on Dietary Supplements, 16% of dietary supplement users said they turned to supplements for mental health support (e.g. anxiety, depression, stress management).
Despite the wide availability of CBD in its various forms—oil, topical ointments, tinctures, vaping and edibles— a recent poll shows parents are misinformed on CBD.
As the uncertainty around the regulatory status of NAC (N-acetyl cysteine) continues, it is important the industry doesn’t lose this for the precedent it sets for other potential ingredients, said CRN’s Steve Mister.
The US Food and Drug Administration has announced that Dr Cara Welch will be the new permanent director of its Office of Dietary Supplement Programs. The announcement was welcomed by industry trade groups.
It started with ten-speed bicycles and ended with an Appeals Court decision in 1983 that changed the herb industry and knocked FDA down a peg. Four decades later, it’s time to shine the spotlight on this game-changing court case.
Representatives Kurt Schrader and Morgan Griffith recently introduced the Hemp and Hemp-Derived CBD Consumer Protection & Market Stabilization Act of 2020.
When it comes to discussing immunity and other health claims, marketers have to be cautious, especially in the current climate. A recent National Advertising Division (NAD) decision stated this is an “unprecedented time” and declared it would fulfill...
Over 70% of Americans take dietary supplements, and by now, most consumers have probably noticed the disclaimer that says "This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.”
FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.
Faecal Microbiota Transplant (FMT) donors should be screened for coronavirus symptoms with checks made of the donor's travel history to regions affected by the virus, an expert panel of researchers say.
The increasing popularity of cannabidiol (CBD) only underscores the need for accurate and informative labeling of hemp and hemp-derived CBD products, according to researchers.
One of the pioneers of the space topped $53 million in annual revenue, but also recorded a loss as the founders cashed out. The firm also said regulatory uncertainty has increased competition as numerous small brands crowd into the field.
The US Food and Drug Administration has stated that it cannot conclude that CBD (cannabidiol) is generally recognized as safe (GRAS) for its use in human food, based on a “lack of scientific information supporting the safety of CBD in food”.
When it comes to legally marketing conventional food and dietary supplements with CBD and other cannabis-derived compounds, FDA and industry appear stuck in a catch-22.
At the Natural Products Expo West show this year, we caught up with the chief strategy and innovation officer at legacy supplement brand Nature’s Way to talk about consumer trends, CBD, and the body of laws that regulate supplements.
A recently posted warning letter cites a New York company for the presence of an aromatase inhibitor in one of its dietary supplements. This class of chemicals is popular with strength trainers for its purported ability to suppress estrogen levels.
FDA’s undertaking to create a master list of ‘old dietary ingredients’ that could be sold legally in dietary supplements without first going through the new dietary ingredient notification process likely will fall flat, despite the agency’s best intentions,...
FDA’s draft guidance on dietary fiber should be significantly amended or tossed out altogether, according to industry trade groups. But at least one company that has been affected by the process believes it adds value to the marketplace.
There have been several cases of the dangerous stimulant 1,3-dimethylamylamine (DMAA) being blocked at the EU borders over the last few months. But what is being done to stem the flow of the outlawed ingredient?
There is a moment at the end of the legendary computer game, Mortal Kombat, where you have just beaten seven shades of something out of your opponent and all that is left is one final blow. ‘Finish him!’ says the game, and you ready your thumbs for the coup...
It’s official, says the FDA. “Synthetically-produced DMAA (1,3-Dimethylamylamine) is not a dietary ingredient and is not, therefore, eligible to be used as an active ingredient in dietary supplements”.
US organic baby formula manufacturer Nature’s One has attacked recent research suggesting that arsenic levels in its toddler formulas were a cause for concern, but the study’s lead author defended the work, even stating that new data published by the...
Regulatory uncertainty in Europe and a string of high-profile lawsuits in the US has made firms much more cautious about making health claims about probiotics, according to one California-based supplier.
A flurry of seizures, criminal charges, and warning letters shows that FDA is increasing it enforcement of dietary supplement regulations. Good for FDA and good for industry!
Should the FDA work to be more like EFSA? Speaking at the NutraIngredients Health Claims 2010 conference Andrew Shao said the two organisations are already very similar in the way they review scientific claims.
In a world with a chronic ‘globesity’ problem spreading beyond western shores to places like India and China, products that promise to help individuals manage their weight via calorie control, fat burning, satiety, or some other mechanism, enjoy rampant...
Each day the US Food and Drug Administration (FDA) dithers in delivering its verdict on the safety of bisphenol A (BPA), its authority is diminished and its credibility wanes.
Foods fortified with omega-3 will be able to continue using a nutrient content claim until at least 2012, despite FDA’s proposed prohibition of the claim.
The Food and Drug Administration (FDA) has told Las Vegas-based Redux Beverages - the maker of controversial energy drink Cocaine - that the powder-like font that adorns its products and marketing contravenes federal law and must be changed.
The dietary supplements industry has applauded a move by the Food
and Drug Administration (FDA) to clamp down on products making
bogus cancer cure claims.
